Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ONMD Stock Forecast 2026-2027
$0.68
Current Price
$39.30M
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to ONMD Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
ONMD Price Momentum
-10.5%
1 Week Change
+21.4%
1 Month Change
+21.4%
1 Year Change
-38.2%
Year-to-Date Change
-83.9%
From 52W High of $4.22
+54.5%
From 52W Low of $0.44
📊 TOP ANALYST CALLS
Did ONMD Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if OneMedNet is one of their latest high-conviction picks.
Latest ONMD Stock Price Targets & Analyst Predictions
ONMD has shown a year-to-date change of -38.2% and a 1-year change of 21.4%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for ONMD. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ONMD Analyst Ratings
0
Buy
0
Hold
0
Sell
ONMD Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $0.68
Latest ONMD Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ONMD.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Onemednet Corp. (ONMD) Competitors
The following stocks are similar to OneMedNet based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Onemednet Corp. (ONMD) Financial Data
Onemednet Corp. has a market capitalization of $39.30M with a P/E ratio of 45.0x. The company generates $1.32M in trailing twelve-month revenue with a -254.3% profit margin.
Revenue growth is -29.9% quarter-over-quarter, while maintaining an operating margin of -2,658.3% and return on equity of +94.5%.
Valuation Metrics
Market Cap
$39.30M
Enterprise Value
$40.16M
P/E Ratio
45.0x
PEG Ratio
-1.3x
Price/Sales
32.0x
Growth & Margins
Revenue Growth (YoY)
-29.9%
Gross Margin
-395.8%
Operating Margin
-2,658.3%
Net Margin
-254.3%
EPS Growth
-29.9%
Financial Health
Cash/Price Ratio
+0.6%
Current Ratio
0.3x
Debt/Equity
-0.2x
ROE
+94.5%
ROA
-385.7%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Onemednet Corp. (ONMD) Business Model
About Onemednet Corp.
What They Do
Healthcare software for medical image management.
Business Model
The company operates on a subscription-based model, offering live data feeds, AI-driven search capabilities, and customized data deliveries to various healthcare stakeholders including pharmaceutical companies, medical device manufacturers, and contract research organizations. Its proprietary iRWD™ platform generates revenue by providing regulatory-grade, AI-ready real-world data that supports evidence generation and model development.
Additional Information
Founded in 2009 and based in Eden Prairie, Minnesota, the company not only focuses on healthcare but also applies its anonymization technology to other sectors such as finance and retail, ensuring secure data management. OneMedNet Corp's innovative solutions contribute to bridging the gap between healthcare providers and life sciences researchers, fostering accelerated innovation in the industry.
Company Information
Sector
Healthcare
Industry
Health Information Services
Employees
22
CEO
Mr. Aaron Green
Country
United States
IPO Year
2019
Website
www.onemednet.comOnemednet Corp. (ONMD) Latest News & Analysis
Latest News
OneMedNet Executes on Growth Strategy: Secures Over $3 Million in New Bookings, Surpassing Full-Year 2025
1 month ago
Quick Summary
OneMedNet Corporation (Nasdaq: ONMD) has secured over $3 million in new bookings for 2026, exceeding its total bookings for all of 2025, with revenue recognition expected by Q3 2026.
Why It Matters
OneMedNet's $3 million in new bookings for 2026, exceeding 2025 totals, signals strong growth and revenue potential, likely boosting investor confidence and stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
OneMedNet Surpasses 90 Million Patient Journeys and 270 Million Studies within its Network
1 month ago
Quick Summary
OneMedNet Corporation (Nasdaq: ONMD) has surpassed 90 million patient journeys and 270 million studies, expanding its partner network to over 2,300 sites, aligning with its long-term growth strategy.
Why It Matters
OneMedNet's growth in patient data and partnerships enhances its market position, signaling strong potential for revenue growth and long-term shareholder value, influencing investment decisions.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
OneMedNet Corporation's iRWD™ Platform is now operational, providing rapid access to billions of records from 80 million patient journeys, enhancing data analysis for life sciences firms.
Why It Matters
OneMedNet's iRWD™ Platform launch enhances data accessibility for life sciences, potentially increasing demand for its services and boosting revenue, impacting stock performance positively.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
OneMedNet reported strong financials for 2025 and advanced its AI-driven iRWD™ technology, powered by Palantir Foundry, to enhance conversational search capabilities on real-time medical data.
Why It Matters
Strong financials and AI advancements indicate growth potential and competitive edge for OneMedNet, likely boosting investor confidence and stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
OneMedNet, Onco-Innovations, and Inka Health have partnered to enhance oncology drug development by leveraging real-world data and analytics.
Why It Matters
The collaboration signals potential advancements in oncology drug development, which may lead to innovative treatments and increased market competitiveness, impacting stock valuations and investor interest.
Source: GlobeNewsWire
Market Sentiment:
Neutral
OneMedNet and Navidence Announce Strategic Collaboration: Empowering Pharma with Precision Real-World Data Insights
4 months ago
Quick Summary
OneMedNet Corporation (Nasdaq: ONMD) has partnered with Navidence to enhance the use of real-world data for pharmaceutical companies, supporting regulatory submissions and AI model training.
Why It Matters
OneMedNet's collaboration with Navidence enhances its position in the RWD market, potentially boosting its revenue and attracting pharma clients needing regulatory compliance and AI integration.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About ONMD Stock
What is Onemednet Corp.'s (ONMD) stock forecast for 2027?
Analyst forecasts for Onemednet Corp. (ONMD) are not currently available. The stock is trading at $0.68.
Is ONMD stock a good investment in 2027?
Analyst ratings for ONMD are not currently available. The stock is currently trading at $0.68. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ONMD stock?
Price predictions from Wall Street analysts for ONMD are not currently available. The stock is trading at $0.68.
What is Onemednet Corp.'s business model?
The company operates on a subscription-based model, offering live data feeds, AI-driven search capabilities, and customized data deliveries to various healthcare stakeholders including pharmaceutical companies, medical device manufacturers, and contract research organizations. Its proprietary iRWD™ platform generates revenue by providing regulatory-grade, AI-ready real-world data that supports evidence generation and model development.
What is the highest forecasted price for ONMD Onemednet Corp.?
Price targets from Wall Street analysts for ONMD are not currently available. The stock is trading at $0.68.
What is the lowest forecasted price for ONMD Onemednet Corp.?
Price targets from Wall Street analysts for ONMD are not currently available. The stock is trading at $0.68.
What is the overall ONMD consensus from analysts for Onemednet Corp.?
Analyst ratings for ONMD are not currently available. The stock is trading at $0.68.
How accurate are ONMD stock price projections?
Stock price projections, including those for Onemednet Corp., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 18, 2026 2:46 AM UTC